EUVIMEDEUVIMED entdecken
Multizentrische Studie

Intracerebral hemorrhage risk after adjunct intraarterial thrombolysis in thrombectomy‐treated acute ischemic stroke

Adnan I Qureshi iD, Yilun Huang, Ibrahim A Bhatti iD, Camilo R Gomez iD, Daniel F Hanley, Daniel E Ford, Ameer E Hassan iD, Thanh N Nguyen, Alejandro M Spiotta, Erol Veznedaroglu, Ronald F Budzik, Rishi Gupta und 6 weitere

Journal of Neuroimaging · 2024

DOI: 10.1111/jon.13238 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neuroimaging, 2024. Verfasst von Adnan I Qureshi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Zeenat Qureshi Stroke Institutes, St Cloud, Minnesota, USA. Hauptthemen laut MEDLINE: Thrombolytic Therapy, Cerebral Hemorrhage, Ischemic Stroke, Thrombectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Stryker Neurovascular.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Intraarterial thrombolysis as an adjunct to mechanical thrombectomy is increasingly being considered to enhance reperfusion in acute ischemic stroke patients. Intraarterial thrombolysis may increase the risk of post‐thrombectomy intracerebral hemorrhage (ICH) in certain patient subgroups.

Methods

We analyzed acute ischemic stroke patients treated with mechanical thrombectomy in a multicenter registry. The occurrence of any (asymptomatic and symptomatic) post‐thrombectomy ICH was ascertained using standard definition requiring serial neurological examinations and computed tomographic scans acquired within 48 hours of the thrombectomy. We determined the risk of ICH in subgroups defined by clinical characteristics and the use of intravenous (IV) thrombolysis.

Results

A total of 146 (7.5%) patients received intraarterial thrombolysis among 1953 acute ischemic stroke patients who underwent mechanical thrombectomy. The proportion of patients who developed any ICH was 26 (17.8%) and 510 (28.2%) among patients who were and were not treated with intraarterial thrombolysis, respectively ( p = .006). The proportion of patients who developed symptomatic ICH was 4 (2.7%) and 30 (1.7%) among patients who were and were not treated with intraarterial thrombolysis, respectively ( p = .34). Among patients who received IV thrombolysis ( n = 1042), the proportion of patients who developed any ICH was 9 (16.7%) and 294 (30.7%) among patients who were and were not treated with intraarterial thrombolysis, respectively ( p = .028). The risk was not different in strata defined by age, gender, location of occlusion, preprocedure National Institutes of Health Stroke Scale score, time interval between symptom onset and thrombectomy, Alberta Stroke Program Early CT Score, systolic blood pressure, and serum glucose concentrations.

Conclusions

In patients undergoing mechanical thrombectomy, the risk of any ICH and symptomatic ICH was not increased with intraarterial thrombolysis, including in those who had already received IV thrombolytics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thrombolytic TherapyCerebral HemorrhageIschemic StrokeThrombectomyFibrinolytic AgentsHumansMaleFemaleAgedMiddle AgedTreatment OutcomeRegistriesCombined Modality TherapyRisk FactorsAged, 80 and over

Stichwörter der Autor:innen

intraarterial thrombolysisintravenous thrombolysisischemic strokemechanical thrombectomymulticenter registry

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • Zeenat Qureshi Stroke Institutes, St Cloud, Minnesota, USA.
  • Department of Neurology, University of Missouri, Columbia, Missouri, USA.
  • Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Internal Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Neurology, Valley Baptist Medical Center Harlingen, Harlingen, Texas, USA.
  • Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.

ORCID-Profile: Adnan I Qureshi, Ibrahim A Bhatti, Camilo R Gomez, Ameer E Hassan, Raul G Nogueira, David S Liebeskind

Förderung

  • Stryker Neurovascular

Zitieren

APA

Qureshi, A. I., Huang, Y., Bhatti, I. A., Gomez, C. R., Hanley, D. F., Ford, D. E., Hassan, A. E., Nguyen, T. N., Spiotta, A. M., Veznedaroglu, E., Budzik, R. F., Gupta, R., Nogueira, R. G., Krajina, A., Bartolini, B., English, J., Baxter, B., & Liebeskind, D. S. (2024). Intracerebral hemorrhage risk after adjunct intraarterial thrombolysis in thrombectomy‐treated acute ischemic stroke. Journal of Neuroimaging. https://doi.org/10.1111/jon.13238

Vancouver

Qureshi AI, Huang Y, Bhatti IA, Gomez CR, Hanley DF, Ford DE, et al. Intracerebral hemorrhage risk after adjunct intraarterial thrombolysis in thrombectomy‐treated acute ischemic stroke. Journal of Neuroimaging. 2024. doi:10.1111/jon.13238

BibTeX
@article{Qureshi2024,
  author = {Qureshi, Adnan I and Huang, Yilun and Bhatti, Ibrahim A and Gomez, Camilo R and Hanley, Daniel F and Ford, Daniel E and Hassan, Ameer E and Nguyen, Thanh N and Spiotta, Alejandro M and Veznedaroglu, Erol and Budzik, Ronald F and Gupta, Rishi and Nogueira, Raul G and Krajina, Antonin and Bartolini, Bruno and English, Joey and Baxter, Blaise and Liebeskind, David S},
  title = {Intracerebral hemorrhage risk after adjunct intraarterial thrombolysis in thrombectomy‐treated acute ischemic stroke},
  journal = {Journal of Neuroimaging},
  year = {2024},
  doi = {10.1111/jon.13238}
}
Kostenlos starten →